As Bayer awaits an FDA decision on its non-hormonal treatment for hot flashes caused by menopause, it's unveiling new results ...

Thursday, Bayer shared top-line data from a phase 3 trial that tested elinzanetant in women on adjuvant endocrine therapy for ...

Bayer AG reported positive results for elinzanetant in women with or at high risk of a type of breast cancer, broadening the use case for the menopause treatment expected to launch as early as this ...

Medically reviewed by Renita White, MD Perimenopause is the transition period when the female body starts to shift from ...

Menopause is a natural biological process that marks the end of a woman's menstrual cycles, typically occurring in the late ...